Top

Published in:

Open Access 01-12-2018

Prevention of HPV-Related Oral Cancer by Dentists: Assessing the Opinion of Dutch Dental Students

Authors: Marcella R. Poelman, Henk S. Brand, Thymour Forouzanfar, Ellen M. Daley, Derk H. Jan Jager

Published in: Journal of Cancer Education | Issue 6/2018

Abstract

The aim of this study is to assess dental students’ opinions of the dentists’ role in primary prevention of human papillomavirus (HPV)-related oral cancer using a cross-sectional web-based survey. A questionnaire, containing questions about knowledge of HPV and oral cancer, confidence in head and neck examination and role of the dentist in preventing HPV-related oral cancer, was sent to all students of the Academic Centre of Dentistry Amsterdam (n = 912). One hundred and twenty-six (n = 126) students completed the questionnaire. Significantly, more master students (75%) than bachelor students (54.3%) were aware that HPV is a causative factor for oral cancer. Master students had more knowledge of HPV than bachelor students, but knowledge about HPV vaccination was irrespective of the study phase. The majority of dental students agreed that it is important to discuss HPV vaccination with patients. Eighty-nine percent of the students think that more education about symptoms of oral cancer will increase screening for oral cancer. Development of a protocol for screening in dental practices was considered even more important. According to dental students, dentists should discuss HPV as a risk factor for oral cancer with patients. Future dentists are willing to be involved in both primary and secondary prevention of HPV-related oral cancer. Therefore, screening for oral cancer and education about HPV vaccination should be integral elements of the dental curriculum.

de Martel FJ, Franceschi S, Vignat J, Bray F, Forman DPM (2012) Global burden of cancers attributable to infections in 2008: a review and synthetic analysis. Lancet Oncol 13:607–615CrossRefPubMed

Farin Kamangar GMD, WFA (2006) Patterns of cancer incidence, mortality, and prevalence across five continents: defining priorities to reduce cancer disparities in different geographic regions of the world. J Clin Oncol 24:2137–2150CrossRefPubMed

Chaturvedi AK, Engels EA, Pfeiffer RM et al (2011) Human papillomavirus and rising oropharyngeal cancer incidence in the United States. J Clin Oncol 29:4294–4301CrossRefPubMedPubMedCentral

Deschler DG, Richmon JD, Khariwala SS, Ferris RLWM (2014) The “new” head and neck cancer patient—young, nonsmoker, nondrinker, and HPV positive: evaluation. Otolaryngol—Head Neck Surg 351:375–380CrossRef

Rietbergen MM, Leemans CR, Bloemena E, Heideman DA, Braakhuis BJ, Hesselink AT, Witte BI, Baatenburg de Jong RJ, Meijer CJ, Snijders PJ, Brakenhoff RH (2013) Increasing prevalence rates of HPV attributable oropharyngeal squamous cell carcinomas in the Netherlands as assessed by a validated test algorithm. Int J Cancer 132:1565–1571CrossRefPubMed

Dahlstrom KR, Li G, Tortolero-Luna G et al (2011) Differences in history of sexual behavior between patients with oropharyngeal squamous cell carcinoma and patients with squamous cell carcinoma at other head and neck sites. Head Neck 33:847–855CrossRefPubMed

Mehanna H, Beech T, Nicholson T et al (2013) Prevalence of human papillomavirus in oropharyngeal and nonoropharyngeal head and neck cancer-systematic review and meta-analysis of trends by time and region. Head Neck 35:747–755CrossRefPubMed

Melchers LJ, Mastik MF, Samaniego Cameron B et al (2015) Detection of HPV-associated oropharyngeal tumours in a 16-year cohort: more than meets the eye. Br J Cancer 112:1349–1357CrossRefPubMedPubMedCentral

Kreimer AR, Clifford GM, Boyle P, Franceschi S (2005) Human papillomavirus types in head and neck squamous cell carcinomas worldwide: a systematic review. Cancer Epidemiol Biomark Prev 14:467–475CrossRef

10.

De Camargo CM, De Souza DLB, Curado MP (2012) International incidence of oropharyngeal cancer: a population-based study. Oral Oncol 48:484–490. doi:10.1016/j.oraloncology.2011.12.013 CrossRef

11.

Arbyn M, De Sanjosé S, Saraiya M et al (2012) EUROGIN 2011 roadmap on prevention and treatment of HPV-related disease. Int J Cancer 131:1969–1982. doi:10.1002/ijc.27650.EUROGIN CrossRefPubMedPubMedCentral

12.

Leemans CR, Braakhuis BJBR (2011) The molecular biology of head and neck cancer. Nat Rev Cancer 11:9–22CrossRefPubMed

13.

Wang MB, Liu IY, Gornbein JA, Nguyen CT (2015) HPV-positive oropharyngeal carcinoma: a systematic review of treatment and prognosis. Otolaryngol - Head Neck Surg 153:758–769. doi:10.1177/0194599815592157 CrossRefPubMed

14.

World Health Organisation (2014) Human papillomavirus vaccines: WHO position paper, October 2014. Wkly Epidemiol Rec 43:465–492. doi:10.1186/1750-9378-2-15 CrossRef

15.

Gillison ML, Chaturvedi AK, Lowy DR (2008) HPV prophylactic vaccines and the potential prevention of noncervical cancers in both men and women. Cancer 113:3036–3046. doi:10.1002/cncr.23764 CrossRefPubMed

16.

Mammas IN, Sourvinos G, Zaravinos A, Spandidos DA (2011) Vaccination against human papilloma virus (HPV): epidemiological evidence of HPV in non-genital cancers. Pathol Oncol Res 17:103–119. doi:10.1007/s12253-010-9288-0 CrossRefPubMed

17.

Bogaards JA, Wallinga J, Brakenhoff RH et al (2015) Direct benefit of vaccinating boys along with girls against oncogenic human papillomavirus: bayesian evidence synthesis. BMJ. doi:10.1136/bmj.h2016

18.

Graham DM, Isaranuwatchai W, Habbous S et al (2015) A cost-effectiveness analysis of human papillomavirus vaccination of boys for the prevention of oropharyngeal cancer. Cancer 121:1785–1792. doi:10.1002/cncr.29111 CrossRefPubMed

19.

Hendry M, Lewis R, Clements A et al (2013) “ HPV? Never heard of it!”: a systematic review of girls ’ and parents ’ information needs, views and preferences about human papillomavirus vaccination. Vaccine 31:5152–5167. doi:10.1016/j.vaccine.2013.08.091 CrossRefPubMed

20.

Fu LY, Bonhomme L-A, Cooper SC et al (2014) Educational interventions to increase HPV vaccination acceptance: a systematic review. Vaccine 32:1901–1920. doi:10.1016/j.vaccine.2014.01.091 CrossRefPubMedPubMedCentral

21.

Williams MU, Carr MM, Goldenberg D (2015) Public awareness of human papillomavirus as a causative factor for oropharyngeal cancer. Otolaryngol - Head Neck Surg:1–6. doi:10.1177/0194599815577781

22.

Khariwala SS, Moore MG, Malloy KM et al (2015) The “HPV discussion”: effective use of data to deliver recommendations to patients impacted by HPV. Otolaryngol Neck Surg 153:518–525. doi:10.1177/0194599815597200 CrossRef

23.

Daley E, Dodd V, DeBate R et al (2014) Prevention of HPV-related oral cancer: assessing dentists’ readiness. Public Health 128:231–238. doi:10.1016/j.puhe.2013.12.002 CrossRefPubMed

24.

Daley EM, Thompson EL, Vamos CA et al (2016) HPV-related knowledge among dentists and dental hygienists. J Cancer Educ:1–6. doi:10.1007/s13187-016-1156-5

25.

Petersen PE (2009) Oral cancer prevention and control—the approach of the World Health Organization. Oral Oncol 45:454–460. doi:10.1016/j.oraloncology.2008.05.023 CrossRefPubMed

26.

Speight PM, Epstein J, Kujan O et al (2017) Screening for oral cancerda perspective from the Global Oral Cancer Forum. Oral Surg Oral Med Oral Pathol Oral Radiol 123:680–687. doi:10.1016/j.oooo.2016.08.021 CrossRefPubMed

27.

Freiser ME, Desai DD, Azcarate PM et al (2016) Educational value of a medical student–led head and neck cancer screening event. Otolaryngol Head Neck Surg 154:638–644. doi:10.1177/0194599815626147 CrossRefPubMed

28.

Dillon M, Smith DJ, Kanatas A (2016) Oral cancer: another challenge for the dental team? Nat Publ Group 220:499–500. doi:10.1038/sj.bdj.2016.357 CrossRef

29.

Daley E, DeBate R, Dodd V et al (2011) Exploring awareness, attitudes, and perceived role among oral health providers regarding HPV-related oral cancers. J Public Health Dent 71:136–142CrossRefPubMed

30.

Dodd RH, Marlow LA V, Waller J (2016) Discussing a diagnosis of human papillomavirus oropharyngeal cancer with patients: an exploratory qualitative study of health professionals. Head Neck 38:394–401. doi:10.1002/hed.23916 CrossRefPubMed

31.

(U.S.) NC for HS, National Center for Health Statistics (2012) Healthy People 2010: final review

32.

Avis NE, Smith KW (2006) Conceptual and methodological issues in selecting and developing quality of life measures. In: Fitzpatrick R, Albrecht GL, Cleary PD, Wilson IB, Fowler FJ, Lerner DJ et al (eds) Advances in medical sociology: quality of life in health care. JAI Press Inc., London, p 255–80

33.

Østerås N, Gulbrandsen P, Garratt A, Benth JS, Dahl FA, Natvig B, Brage S (2008) A randomised comparison of a four- and a five-point scale version of the Norwegian Function Assessment Scale. Health Qual Life Outcomes 6:14. doi:10.1186/1477-7525-6-14

34.

Mohyuddin N, Langerman A, LeHew C et al (2008) Knowledge of head and neck cancer among medical students at 2 Chicago universities. Arch Otolaryngol Head Neck Surg 134:1294–1298. doi:10.1001/archotol.134.12.1294 CrossRefPubMed

35.

Grover N, Prakash A, Singh S et al (2014) Attitude and knowledge of dental students of National Capital Region regarding HIV and AIDS. J Oral Maxillofac Pathol 18:9–13. doi:10.4103/0973-029X.131882 CrossRefPubMedPubMedCentral

36.

Sahin I, Rogers F (2006) Detailed review of Rogers’ diffusion of innovations theory and educational technology-related studies based on Rogers. Turkish Online J Educ Technol 5:14–23

37.

Krouwel EM, Hagen JH, Nicolai MPJ et al (2015) Management of sexual side effects in the surgical oncology practice: a nationwide survey of Dutch surgical oncologists. Eur J Surg Oncol 41:1179–1187. doi:10.1016/j.ejso.2015.06.009 CrossRefPubMed

38.

van Ek GF, Krouwel EM, Nicolai MP et al (2015) Discussing sexual dysfunction with chronic kidney disease patients: practice patterns in the Office of the Nephrologist. J Sex Med 12:2350–2363. doi:10.1111/jsm.13062 CrossRefPubMed

Title: Prevention of HPV-Related Oral Cancer by Dentists: Assessing the Opinion of Dutch Dental Students
Authors: Marcella R. Poelman
Henk S. Brand
Thymour Forouzanfar
Ellen M. Daley
Derk H. Jan Jager
Publication date: 01-12-2018
Publisher: Springer US
Published in: Journal of Cancer Education / Issue 6/2018
Print ISSN: 0885-8195
Electronic ISSN: 1543-0154
DOI: https://doi.org/10.1007/s13187-017-1257-9

Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Watch now

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras

Prof. Fabrice Barlesi

Developed by: Springer Medicine

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Abstract

Please log in to get access to this content

Other articles of this Issue 6/2018

Video Education on Hereditary Breast and Ovarian Cancer (HBOC) for Physicians: an Interventional Study

Is Cancer Information Exchanged on Social Media Scientifically Accurate?

Knowledge and Preferences of Primary Care Providers in Delivering Head and Neck Cancer Survivorship Care

News from the European Association for Cancer Education: a Long-standing Partner of AACE

Cancer Survivors’ Reported Discussions with Health Care Providers About Follow-Up Care and Receipt of Written Care Plans

Assessing the Feasibility and Effectiveness of an App in Improving Knowledge on Oral Cancer—an Interventional Study

Keynote webinar | Spotlight on antibody–drug conjugates in cancer